Sangamo Therapeutics, Inc. SGMO
Set alert
0.07 USD 0.00 0.00%
At close · Jul 1
0.15 +0.07 +98.38%
After hours · Jul 1, 4:00 PM ET
0.0637 Day range 0.13
52-week range unavailable
- YTD
- -82.38%
- 1 year
- -87.29%
- Open
- 0.13
- Prev close
- 0.074
- Mkt cap
- 30.66M
- Vol
- 28.50M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0637
- High
- 0.13
- Forward P/E
- -10.86
- Beta
- 0.00
- Short ratio
- 1.70
- Inst. own
- 27.02%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.94
- 200-d avg
- 0.98075
- 1y target
- 6.33
Analyst view
Consensus: buy
Buy
Price target (mean) 6.33 +8458.6% upside
Now 0.074
- Target (low)
- 2.00
- Target (mean)
- 6.33
- Target (high)
- 10.00
Ratings (0m) 8 5 buy · 3 hold · 0 sell
- Strong buy2
- Buy3
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 8
- 1 month ago 8
- 2 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 8.84M | +333.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 31.50M | +6448.9% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 59.15M | -66.4% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 96.49M | +63.1% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 20, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 19, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 10, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 14, 2024 | Barclays | Maintained | Overweight | Overweight |
| Nov 5, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 23, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 22, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 22, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 31, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 24, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 19, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 14, 2024 | RBC Capital | Reiterated | Sector Perform | Sector Perform |
| Mar 13, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Feb 12, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 19, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 7, 2023 | Truist Securities | Downgrade | Buy | Hold |
| Nov 6, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 6, 2023 | Wells Fargo | Downgrade | Overweight | Equal-Weight |
| Nov 3, 2023 | RBC Capital | Downgrade | Outperform | Sector Perform |
| Aug 15, 2023 | Truist Securities | Maintained | Buy | Buy |
| Aug 14, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 11, 2023 | Wedbush | Maintained | Outperform | Outperform |
| Aug 10, 2023 | Wells Fargo | Maintained | Overweight | Overweight |
| Aug 9, 2023 | Barclays | Maintained | Overweight | Overweight |
| Aug 9, 2023 | RBC Capital | Maintained | Outperform | Outperform |
| May 10, 2023 | Truist Securities | Maintained | Buy | Buy |
| May 1, 2023 | HC Wainwright & Co. | Maintained | — | Buy |